Literature DB >> 24627328

Regulation of alternative splicing of tau exon 10.

Wei Qian1, Fei Liu.   

Abstract

The neuronal microtubule-associated protein tau is abnormally hyperphosphorylated and aggregated into neurofibrillary tangles in the brains of individuals with Alzheimer's disease and related neurodegenerative disorders. The adult human brain expresses six isoforms of tau generated by alternative splicing of exons 2, 3, and 10 of its pre-mRNA. Exon 10 encodes the second microtubule-binding repeat of tau. Its alternative splicing produces tau isoforms with either three or four microtubule-binding repeats, termed 3R-tau and 4Rtau. In the normal adult human brain, the level of 3R-tau is approximately equal to that of 4R-tau. Several silent and intronic mutations of the tau gene associated with FTDP-17T (frontotemporal dementia with Parkinsonism linked to chromosome 17 and specifically characterized by tau pathology) only disrupt exon 10 splicing, but do not influence the primary sequence of the tau protein. Thus, abnormal exon 10 splicing is sufficient to cause neurodegeneration and dementia. Here, we review the regulation of tau exon 10 splicing by cis-elements and trans-factors and summarize all the mutations associated with FTDP-17T and related tauopathies. The findings suggest that correction of exon 10 splicing may be a potential target for tau exon 10 splicing-related tauopathies.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24627328      PMCID: PMC5562657          DOI: 10.1007/s12264-013-1411-2

Source DB:  PubMed          Journal:  Neurosci Bull        ISSN: 1995-8218            Impact factor:   5.203


  96 in total

1.  Pick's disease associated with the novel Tau gene mutation K369I.

Authors:  M Neumann; W Schulz-Schaeffer; R A Crowther; M J Smith; M G Spillantini; M Goedert; H A Kretzschmar
Journal:  Ann Neurol       Date:  2001-10       Impact factor: 10.422

2.  Ser/Thr-specific protein phosphatases are required for both catalytic steps of pre-mRNA splicing.

Authors:  J E Mermoud; P Cohen; A I Lamond
Journal:  Nucleic Acids Res       Date:  1992-10-25       Impact factor: 16.971

3.  Structure and novel exons of the human tau gene.

Authors:  A Andreadis; W M Brown; K S Kosik
Journal:  Biochemistry       Date:  1992-11-03       Impact factor: 3.162

Review 4.  Tau protein as a differential biomarker of tauopathies.

Authors:  Nicolas Sergeant; André Delacourte; Luc Buée
Journal:  Biochim Biophys Acta       Date:  2005-01-03

Review 5.  Mutations causing neurodegenerative tauopathies.

Authors:  Michel Goedert; Ross Jakes
Journal:  Biochim Biophys Acta       Date:  2005-01-03

6.  RNA helicase p68 (DDX5) regulates tau exon 10 splicing by modulating a stem-loop structure at the 5' splice site.

Authors:  Amar Kar; Kazuo Fushimi; Xiaohong Zhou; Payal Ray; Chen Shi; Xiaoping Chen; Zhiren Liu; She Chen; Jane Y Wu
Journal:  Mol Cell Biol       Date:  2011-02-22       Impact factor: 4.272

7.  Novel L284R MAPT mutation in a family with an autosomal dominant progressive supranuclear palsy syndrome.

Authors:  Jonathan D Rohrer; Dominic Paviour; Jana Vandrovcova; John Hodges; Rohan de Silva; Martin N Rossor
Journal:  Neurodegener Dis       Date:  2010-09-14       Impact factor: 2.977

8.  Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I.

Authors:  F Rossi; E Labourier; T Forné; G Divita; J Derancourt; J F Riou; E Antoine; G Cathala; C Brunel; J Tazi
Journal:  Nature       Date:  1996-05-02       Impact factor: 49.962

9.  Heterogeneous nuclear ribonucleoprotein E3 modestly activates splicing of tau exon 10 via its proximal downstream intron, a hotspot for frontotemporal dementia mutations.

Authors:  Yan Wang; Lei Gao; Sze-Wah Tse; Athena Andreadis
Journal:  Gene       Date:  2009-11-12       Impact factor: 3.688

10.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

Authors:  M Goedert; M G Spillantini; R Jakes; D Rutherford; R A Crowther
Journal:  Neuron       Date:  1989-10       Impact factor: 17.173

View more
  33 in total

Review 1.  Therapeutic Strategies for Restoring Tau Homeostasis.

Authors:  Zapporah T Young; Sue Ann Mok; Jason E Gestwicki
Journal:  Cold Spring Harb Perspect Med       Date:  2018-01-02       Impact factor: 6.915

2.  Tau isoform expression and phosphorylation in marmoset brains.

Authors:  Govinda Sharma; Anni Huo; Taeko Kimura; Seiji Shiozawa; Reona Kobayashi; Naruhiko Sahara; Minaka Ishibashi; Shinsuke Ishigaki; Taro Saito; Kanae Ando; Shigeo Murayama; Masato Hasegawa; Gen Sobue; Hideyuki Okano; Shin-Ichi Hisanaga
Journal:  J Biol Chem       Date:  2019-06-05       Impact factor: 5.157

3.  Alzheimer's disease: from molecule to clinic.

Authors:  Jian-Zhi Wang
Journal:  Neurosci Bull       Date:  2014-04       Impact factor: 5.203

Review 4.  Genetics of Frontotemporal Dementia.

Authors:  Diana A Olszewska; Roisin Lonergan; Emer M Fallon; Tim Lynch
Journal:  Curr Neurol Neurosci Rep       Date:  2016-12       Impact factor: 5.081

5.  Transactive response DNA-binding protein 43 (TDP-43) regulates alternative splicing of tau exon 10: Implications for the pathogenesis of tauopathies.

Authors:  Jianlan Gu; Feng Chen; Khalid Iqbal; Cheng-Xin Gong; Xinglong Wang; Fei Liu
Journal:  J Biol Chem       Date:  2017-05-09       Impact factor: 5.157

Review 6.  Tau and neurodegenerative disease: the story so far.

Authors:  Khalid Iqbal; Fei Liu; Cheng-Xin Gong
Journal:  Nat Rev Neurol       Date:  2015-12-04       Impact factor: 42.937

7.  Isoform-independent and -dependent phosphorylation of microtubule-associated protein tau in mouse brain during postnatal development.

Authors:  Dilina Tuerde; Taeko Kimura; Tomohiro Miyasaka; Kotaro Furusawa; Aki Shimozawa; Masato Hasegawa; Kanae Ando; Shin-Ichi Hisanaga
Journal:  J Biol Chem       Date:  2017-12-01       Impact factor: 5.157

8.  Impaired tau-microtubule interactions are prevalent among pathogenic tau variants arising from missense mutations.

Authors:  Yuxing Xia; Zachary A Sorrentino; Justin D Kim; Kevin H Strang; Cara J Riffe; Benoit I Giasson
Journal:  J Biol Chem       Date:  2019-10-24       Impact factor: 5.157

Review 9.  The propagation mechanisms of extracellular tau in Alzheimer's disease.

Authors:  Yun Wei; Meixia Liu; Dongxin Wang
Journal:  J Neurol       Date:  2021-04-28       Impact factor: 4.849

10.  Closing the tau loop: the missing tau mutation.

Authors:  Allan McCarthy; Roisin Lonergan; Diana A Olszewska; Sean O'Dowd; Gemma Cummins; Brian Magennis; Emer M Fallon; Niall Pender; Edward D Huey; Stephanie Cosentino; Killian O'Rourke; Brendan D Kelly; Martin O'Connell; Isabelle Delon; Michael Farrell; Maria Grazia Spillantini; Lewis P Rowland; Stanley Fahn; Peter Craig; Michael Hutton; Tim Lynch
Journal:  Brain       Date:  2015-08-21       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.